Vimarsana
Biggest News Aggregation in the World

Page 43 - Study Design News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Study Design. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Study Design Today - Breaking & Trending Today

FDA Posts Draft Guidance for Pharma Companies, Sponsors, and Researchers on Using Real-World Data from Health Records in Clinical Studies | Faegre Drinker Biddle & Reath LLP - Vimarsana News

FDA Posts Draft Guidance for Pharma Companies, Sponsors, and Researchers on Using Real-World Data from Health Records in Clinical Studies | Faegre Drinker Biddle & Reath LLP

The U.S. Food and Drug Administration (FDA) has issued a draft guidance for pharmaceutical companies, sponsors, and researchers sourcing Real World Data (RWD) from health records. As...

Clinical Trial Management System Market to reach US$ 1,941.4 Mn by end of 2027, Says Coherent Market Insights - Vimarsana News

Clinical Trial Management System Market to reach US$ 1,941.4 Mn by end of 2027, Says Coherent Market Insights

/PRNewswire/ -- A Clinical Trial Management System (CTMS) is an effective software application utilized by pharmaceutical and biotechnology industries...

Clinical Trial Management System Market to reach US$ 1,941.4 Mn by end of 2027, Says Coherent Market Insights - Vimarsana News

Clinical Trial Management System Market to reach US$ 1,941.4 Mn by end of 2027, Says Coherent Market Insights

/PRNewswire/ -- A Clinical Trial Management System (CTMS) is an effective software application utilized by pharmaceutical and biotechnology industries...

Mitsubishi Tanabe Pharma America Announces Presentations at 146th Annual Meeting of the American Neurological Association - Vimarsana News

Mitsubishi Tanabe Pharma America Announces Presentations at 146th Annual Meeting of the American Neurological Association

/PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that two abstracts on amyotrophic lateral sclerosis (ALS) will be presented...

Neurology Clinical Trials Market Size Worth $7.4 Billion By 2028: Grand View Research, Inc. - Vimarsana News

Neurology Clinical Trials Market Size Worth $7.4 Billion By 2028: Grand View Research, Inc.

/PRNewswire/ -- The global neurology clinical trials market size is expected to reach USD 7.4 billion by 2028, according to a new report by Grand View...